Ten compounds with published human trial data. Approved medicines first, then late-stage investigational molecules — statuses are stated plainly on every listing.
First time here? Read the beginner's guide →
The active ingredient in Ozempic and Wegovy — the original once-weekly weight-loss medicine.
GLP-1 receptor agonist
The active ingredient in Mounjaro and Zepbound — the newer, stronger once-weekly weight-loss medicine.
Dual GIP / GLP-1 receptor agonist
A once-weekly weight-loss medicine already approved in China — still experimental in Canada and the US.
Dual GLP-1 / glucagon receptor agonist
An experimental medicine that works three ways at once — in late-stage testing, not approved anywhere yet.
Triple GIP / GLP-1 / glucagon receptor agonist
An experimental medicine that curbs appetite and boosts calorie burn — in late-stage testing.
Dual glucagon / GLP-1 receptor agonist
Two weight-loss medicines in one shot — an amylin drug plus a GLP-1, combined.
Amylin analogue + GLP-1 (fixed-dose combination)
Viking’s dual-action weight-loss drug — the same two pathways as tirzepatide, with the fastest onset ever reported.
Dual GIP / GLP-1 receptor agonist
An experimental appetite medicine that works differently from the GLP-1 shots — in late-stage testing.
Long-acting amylin analogue
An experimental once-weekly appetite medicine in earlier testing — one to watch.
Amylin analogue (once-weekly)
An experimental combo shot — an amylin drug stacked on tirzepatide. Very early testing.
Amylin analogue + dual GIP/GLP-1 (combination)
The two sterile diluents our compounds are designed to be reconstituted with. Same volume discounts, same $15 flat shipping.
Sterile water with a preservative — the standard liquid used to dissolve freeze-dried peptides for lab work.
Sterile diluent
Pure sterile water with no preservative — for single-use lab work.
Sterile diluent
